Urogen Pharma Ltd (URGN)

Is Urogen Pharma Ltd (URGN) A Buy Now?

According to our latest analysis, URGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 14 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on URGN, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 19.29 indicates that URGN is oversold. This indicates that URGN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
2. STOCH (Stochastic Oscillator): The STOCH value of 25.00 indicates that URGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that URGN is overbought. This suggests that URGN price is at or near the highest level relative to its recent price history.
4. ADX (Average Directional Index): The ADX value of 38.69 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
5. CCI (Commodity Channel Index): A CCI(14) value of -175.27 indicates that URGN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term URGN price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Urogen Pharma Ltd financial reports and earnings history, Urogen Pharma Ltd (URGN) stock could reach $28.71 by 2030, $58.11 by 2040 and $65.78 by 2050. See the projected annual prices until 2050 of the Urogen Pharma Ltd stock below:

• Urogen Pharma Ltd (URGN) is expected to reach an average price of $37.47 in 2035, with a high prediction of $44.96 and a low estimate of $34.73. This indicates an +45.62% change from the last recorded price of $25.73.
• Urogen Pharma Ltd (URGN) stock is projected to chart a bullish course in 2040, with an average price target of $50.40, representing an +95.86% change from its current level. The forecast ranges from a conservative $42.48 to a sky-high $58.11.
• Our analysts predict Urogen Pharma Ltd (URGN) to change +131.39% by 2045, soaring from $49.57 to an average price of $59.54, potentially reaching $69.44. While $49.57 is the low estimate, the potential upside is significant.
• Urogen Pharma Ltd (URGN) stock is expected to climb by 2050, reaching an average of $64.81, a +151.90% change from its current level. However, a wide range of estimates exists, with high and low targets of $65.78 and $55.52, respectively, highlighting the market's uncertainty.

Urogen Pharma Ltd Stock (URGN) Year by Year Forecast